RVNC
Revance Therapeutics, Inc.
CEO Mark J Foley bought $209K of Revance Therapeutics, Inc.
Bought$209,400
$6.98Price
30,000Shares
+3%Stake
What RVNC did for a copier
Prices for RVNC after this filing aren't in yet.
Mark J Foley's record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Mar 6. Filed Fri, Mar 8, 11:33 AM ET, during the session. Not investment advice.